EA
BIVV

Edge Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Edge Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11
Closed – – 992
2017
Q4 		$0 Hold
11
– – ﹤0.01% 999
2017
Q3 		$0 Hold
11
– – ﹤0.01% 1037
2017
Q2 		$0 Sell
11
-25
-69% -$1.42K ﹤0.01% 1063
2017
Q1 		$1K Buy
+36
New +$1.77K ﹤0.01% 918

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Edge Advisors's BIVV Position: Q1 2018 in Review

Edge Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 11 shares.

Edge Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Edge Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Edge Advisors sold 11 Bioverativ Inc. Common Stock shares in Q1 2018.
  • Edge Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Edge Advisors's Bioverativ Inc. Common Stock position peaked at $1K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Edge Advisors's 13F filing for Q1 2018, filed 15 May 2018.